Anthim OverviewObiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax). This drug was developed by Elusys Therapeutics, Inc. Contents 1 Society and culture 1.1 Legal status 2 References 3 External links Society and culture Legal status On 17 September 2020, the Committee for Medicinal Products for...
Read more Anthim Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obiltoxaximab
Recent Anthim Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 600mg/6ml
NDC Database Records for Anthim: (1 result)Sorted by National Drug Code
- 69604-204 Anthim 100 mg/ml Intravenous Solution by Elusys Therapeutics, Inc.